WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹109 Cr | ₹61 Cr | ₹9.13 Cr | ₹11 Cr | ₹25 Cr |
What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹109 Cr |
Mar2023 | ₹61 Cr |
Mar2022 | ₹9.13 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹25 Cr |
How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹109 Cr | 78.73 | |
Mar2023 | ₹61 Cr | 567.74 | |
Mar2022 | ₹9.13 Cr | -20.30 | |
Mar2021 | ₹11 Cr | -54.19 | |
Mar2020 | ₹25 Cr | - |
Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,032.1 Cr | 4% | 1.4% | 116% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | 4% |
1.4% |
116% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses